Introduction
Lung cancer remains one of the most fatal diseases globally, with its prognosis strongly influenced by the stage at which treatment begins. The mortality rate from lung cancer is alarmingly high, and most patients only consult a physician once symptoms manifest—setting off the diagnostic journey. General practitioners (GPs) must be equipped with the best diagnostic tools to enable early detection. Understanding the diagnostic pathway and associated pre-diagnostic processes, including the utilization of fast-track programs in primary care, is essential (Tammemagi, 2014). Although chest radiography is commonly used as the primary diagnostic tool, its low sensitivity and potential for false negatives can cause delays. In contrast, Low-Dose Multi-Detector Computed Tomography (LD-MDCT) offers superior sensitivity, albeit at a higher cost and greater radiation exposure compared to traditional chest X-rays.
Critique Focus
This critique focuses on the study titled "The effect of direct access to CT scan in early lung cancer detection: An unblinded, cluster-randomized trial" by Guldbrandt et al. (2015), which was found in the National Institute for Health and Care Excellence (NICE) database using specific keywords from 2013 onwards. The study looks at whether allowing GPs to send patients directly for LDCT can lead to earlier lung cancer detection. It addresses the poorer survival rates found in nations such as Denmark and the United Kingdom, which are largely related to diagnostic delays (Guldbrandt et al., 2015). The major purpose was to improve understanding of how lung cancer is detected in general practice and to assess the impact of including LDCT as a diagnostic tool.
Methods
A cluster-randomized controlled trial was conducted over 19 months in Aarhus municipality, Denmark (population ~300,000). Randomization and interventions occurred at the practice level (Guldbrandt et al., 2015), involving 266 physicians across 119 practices and 331 lung cancer patients. The intervention consisted of direct access to LDCT and a one-hour cancer update meeting. GPs could refer patients for LDCT if they presented symptoms suggestive of lung cancer but did not qualify for the fast-track referral pathway (Alberg et al., 2013).
Study Design
Inclusion criteria required patients to have a new lung cancer diagnosis and to be treated by a participating GP. No exclusions were specified. GPs had three diagnostic options: request a chest radiograph, refer to the 72-hour fast-track pathway, or place the patient on a standard referral list at Aarhus University Hospital. Fast-track criteria included red-flag symptoms such as hemoptysis or a persistent cough over four weeks, or abnormal chest X-ray results (Guldbrandt et al., 2015). Patients were selected after a two-month run-in period beginning in January 2012, with data sourced monthly from the Danish National Patient Registry (NPR) and the Danish Lung Cancer Registry (DLCR).
GP Questionnaire
Participating GPs received a brief questionnaire and were reminded after four weeks if they had not responded. Each active GP was compensated (€17/£15) and was asked to consult patient records to answer questions on diagnostic pathways, use of the fast-track system, and relevant dates (Guldbrandt et al., 2015).
Randomization
Randomization was conducted in Stata 12.0 using the practice addresses, with each of the 119 practices assigned a random number between 0 and 1. The 60 practices with the highest values were allocated to the intervention group.
Hypotheses of the Intervention
The researchers hypothesized that direct LDCT access would enable quicker diagnoses by bypassing the limitations of chest radiographs (Smith et al., 2013). Other assumptions included improved diagnostic intervals when doctors recognized early lung cancer symptoms and the idea that continuity of care (knowing the patient personally) could lead to more accurate referrals. LDCT was expected to catch more cases, especially at earlier stages, and increase the rate of fast-track referrals, potentially raising the Positive Predictive Value (PPV) of the pathway.
Intervention Details:
Within the first three months, GPs received training on LDCT criteria, PPVs, and referral protocols. They were added to algorithms for early diagnosis of lung cancer by Rogers (2012). Initially, 90 patients got contrast-enhanced MDCT scanning, but this was changed to non-contrast LDCT due to a large volume of referrals, long scan durations, and a desire to limit radiation exposure (Schichtel, 2013). Patients with unclassifiable nodules were scheduled for follow-ups in three, six, or twelve months.
Statistical Analysis
Comparisons between intervention and control groups were performed using Wilcoxon rank and Pearson’s chi-square tests (Guldbrandt et al., 2015). Primary analyses followed an intention-to-treat approach, reflecting the randomization at the GP level. Diagnostic intervals and primary care timelines were reported as medians with interquartile intervals. The researchers used general linear models (GLM) with a binomial family to evaluate associations with longer diagnostic intervals.
Baseline Characteristics
Intervention GPs were more likely to work solo, were slightly older (mean age 53.6 vs. 51.6), and tended to have more socioeconomically disadvantaged patients. Around 48.5% of these GPs participated in the Continuing Medical Education (CME) session. Across groups, patients were similar in age, gender, education, marital status, and comorbidity levels (Guldbrandt et al., 2015).
Diagnostic and Primary Care Intervals
The median primary care interval across all patients was 16 days (IQI: 4–56), while the total diagnostic interval median was 39 days (IQI: 17–93). There was no statistically significant difference between the control and intervention groups overall. However, among GPs who attended CME, both intervals were significantly shorter (diagnostic median: 23 vs. 66 days, p=0.008; primary care median: 9 vs. 37 days) (Guldbrandt et al., 2015). Adjusted analyses showed a non-significant trend toward longer diagnostic intervals in the control group (RD: 13.5%, p=0.28).
Cancer Staging
Approximately 34.7% of cases were diagnosed at the localized stage. Even after accounting for noncompliance, there was no significant difference in stage distribution between the control and intervention groups (RD: 1.5%, p=0.927). Around 836 people were sent through the fast-track pathway, and 81 were eventually diagnosed with lung cancer, resulting in a PPV of 9.7%. Advanced-stage cancer was detected in 59.3% of patients, with no significant difference between the two groups.
Discussion
The study’s cluster-randomized design accounted for the similarity among patients treated by the same GP, requiring a larger sample to maintain statistical power (Gould et al., 2013). By recruiting all GPs in Aarhus who referred patients to the central hospital, the study ensured comprehensive and consistent patient data collection (Alberg et al., 2013). However, this may have reduced the overall number of GPs and patients included. The intervention itself—granting direct LDCT access and providing CME—was structured to improve early diagnosis. Educational components were essential, as introducing new diagnostic tools without adequate training could lead to inefficiencies (Davidson, 2013).
Questionnaire Validity
The questionnaire’s design drew from previous validated studies to ensure content accuracy (Smith et al., 2013). It was also pilot-tested to enhance its reliability. Still, using standardized scales could have further strengthened the outcome assessments.
Statistical Precision
The high response rate (81%) minimized selection bias. Additionally, patient characteristics were similar across both groups, reinforcing the study’s internal validity (Hamilton, 2014).
Results Summary
Direct LDCT access had no meaningful effect on the time to diagnosis or the cancer stage at diagnosis. However, after accounting for noncompliance, the control group had a greater risk of longer diagnostic intervals (Guldbrandt et al., 2015). Of the 331 lung cancer cases detected, over half were linked to GPs who had attended the CME. The findings show that combining direct LDCT access with GP education leads to speedier diagnosis, although bigger trials are needed to validate these findings (Rogers, 2012).
Stage at Diagnosis
Using LDCT, approximately 40% of lung cancers were detected at stage I. However, to confirm its true benefit, a concurrent drop in late-stage diagnoses must also be observed. The 19-month duration of the study may not be sufficient to demonstrate shifts in cancer stage, given the slow progression of the disease.
Conclusion and Future Perspectives
Approximately two-thirds of patients underwent diagnostic evaluations prior to receiving a confirmed diagnosis, with one in four routed through the fast-track system. Nearly 90% underwent at least one chest radiograph before being diagnosed, and about one-third had multiple X-rays in the three months leading up to their diagnosis. Extended diagnostic timelines were linked to factors such as patient age, how GPs interpreted presenting symptoms, and the type of referral pathway used. Enhancing primary care with direct-access diagnostic options embedded within fast-track frameworks appears to hold significant potential for improving early detection.
Training improved GP readiness to utilize LDCT, and approximately 2.3% of referred patients were diagnosed with lung cancer—half of whom required further evaluation. LDCT effectively identified various lung diseases. One major critique is the absence of a significant impact on diagnostic time or cancer stage between control and intervention groups. Future research should assess whether integrating direct LDCT access with fast-track pathways improves outcomes. Lastly, direct LDCT access should be considered for symptomatic, unscreened patients as a viable alternative to formal lung cancer screening programs.
References
Ratings
